EICHOR
● Completed
A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise
Condition: Type 2 Diabetes Mellitus · Sponsor: Shenzhen HighTide Biopharmaceutical Ltd.
About this study
The goal of this clinical trial is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to placebo in patients with type 2 diabetes inadequately controlled with diet and exercise alone.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (14)
| Peking University People's Hospital | Beijing, China | — |
| The Second Hospital of Jilin University | Changchun, China | — |
| The First People's Hospital of Changde City | Changde, China | — |
| The Fourth Affiliated Hospital of Harbin Medical University | Harbin, China | — |
| Huizhou Municipal Central Hospital | Huizhou, China | — |
| Jinan Central Hospital | Jinan, China | — |
| Liaocheng People's Hospital | Liaocheng, China | — |
| The First Affiliated Hospital of Henan University of Science and Technology | Luoyang, China | — |
| Nanjing First Hospital | Nanjing, China | — |
| Nanjing Jiangning Hospital | Nanjing, China | — |
| Sir Run Run Hospital Nanjing Medical University | Nanjing, China | — |
| The First Affiliated Hospital of Nanyang Medical College | Nanyang, China | — |
+ 2 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06411275